Litigation

HB Ad Slot
HB Mobile Ad Slot

The National Law Review is a no-log-in resource of legal articles addressing litigation, trial practice, appellate practice, and alternative dispute resolution. We provide legal news on the most recent litigated business and commercial cases including antitrust, banking and financial institutions, construction, complex disputes/class actions involving multi-parties and multi-jurisdictions, communications, employment law, environmental actions, government enforcement defense, insurance, intellectual property, mergers and business combinations, products liability, professional liability, real estate and development, environmental, securities enforcement, white-collar criminal actions, and trust and estate litigation. Details of actions by federal and state and local regulatory agencies as well as private actions from across the U.S. are added daily.

The legal experts who write for the National Law Review cover the federal circuit courts as well as the Supreme Court, analyzing the decisions and opinions from the justices at these levels and parsing the meaning and greater context of these decisions.  For coverage of the circuit courts and the decisions at the Supreme Court, the National Law Review has breaking news coverage of these issues. Additionally, coverage of litigation as a process, including rules of evidence, jury selection, and information on expert witnesses is available on the site.

Along with traditional litigation, the National Law Review also covers alternate dispute resolution (ADR), as well as the viability of Arbitration Agreements in a variety of contexts. The benefits of mediation as opposed to litigation, and the benefits of arbitration.  Compulsory arbitration clauses in agreements relating to major corporations, shareholder agreements, or multinational agreements, are covered on the National Law Review.

Additionally, the National Law Review covers trends in -e-discovery and regulations in document analysis and trial preparation. 

We also serve as a resource for the latest developments in civil proceduree-discovery, trial practice, appellate practice, and alternative dispute resolution, including mediation and arbitration involving both binding adversarial proceedings and non-binding voluntary procedures before neutral third parties.

National Law Review Litigation & Class Action Law TwitterFor hourly updates on the latest news about Litigation, Class Action Law Suits, Appellate Rulings, TCPA, and more, be sure to follow our Litigation Law X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Litigation, Trial, ADR, E-Discovery & Court News

Title
Custom text Organization Sort descending
May
16
2017
Midland Funding Highlights Peculiar Feature of Wisconsin's Statute-of-Limitations Law Foley & Lardner LLP
Jul
31
2018
FDA Xyrem Meeting Materials Qualify As Printed Publication Foley & Lardner LLP
Feb
29
2024
Generative AI Systems Tee Up Fair Use Fight Foley & Lardner LLP
May
24
2016
Federal Circuit Affirms Finacea Gel Infringement Under Doctrine of Equivalents Foley & Lardner LLP
May
25
2017
Fleeting Glimpse of RESPA Issues in PHH Argument as Court Focuses on Bureau Constitutionality Foley & Lardner LLP
Mar
13
2024
SEC v Panuwat: The SEC’s Novel “Shadow Trading” Insider Trading Case Goes to Trial Foley & Lardner LLP
Aug
27
2018
Seventh Circuit Requires a Defendant Seeking Removal To Establish the Plaintiffs’ Article III Standing Foley & Lardner LLP
Jun
30
2015
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
Oct
29
2019
A Review of Recent Whistleblower Developments: October 29, 2019 Foley & Lardner LLP
Oct
7
2020
Federal Circuit Orders Partial Dismissal of Voip-Pal’s IPR Challenged Claims Foley & Lardner LLP
Nov
4
2019
HR and HSR: Insider Purchases and Executive Compensation Can Require Antitrust Reporting Foley & Lardner LLP
Feb
23
2023
Federal Circuit Weighs In On Patent Eligibility Of Isolated Vitamin Foley & Lardner LLP
Jul
18
2017
Are State-Owned Patents Immune From IPRs Under The Eleventh Amendment? Foley & Lardner LLP
Nov
5
2020
Miles of Deceit: Protecting Yourself From Duplicitous Dealers Selling Out Foley & Lardner LLP
Nov
18
2020
What Arthrex Could Mean for the PTAB Going Forward Foley & Lardner LLP
Nov
8
2018
PTAB Boardside Chat Provides Further Details About New Amendment Procedure Foley & Lardner LLP
Aug
11
2015
Invalidity Argument Without a Home? PTAB's Discretion to Ignore Grounds for Invalidity Foley & Lardner LLP
Mar
29
2023
The BioPharma Patent Cliff: 2023 and Beyond Foley & Lardner LLP
Aug
15
2017
Federal Circuit Criticizes PTAB Reliance On Routine Testing Foley & Lardner LLP
Aug
19
2015
Two Bites, Taken Together: Parallel and Serial IPR Petitions Foley & Lardner LLP
Dec
15
2020
Arthrex Amicus Briefs – Novel Arguments for the Court To Consider Foley & Lardner LLP
Aug
25
2015
PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge Foley & Lardner LLP
Dec
17
2020
Article III Standing in FDCPA Class Actions: The Seventh Circuit Issues a Series of Decisions Foley & Lardner LLP
Aug
27
2015
Amgen And Apotex Do The Biosimilar Patent Dance Foley & Lardner LLP
Jan
3
2022
Get Your Popcorn – The Supreme Court is Back in Session Foley & Lardner LLP
Jan
10
2022
The Supreme Court has Heard Arguments on COVID-19 Vaccine Mandates. And Now, We Wait Foley & Lardner LLP
Oct
3
2017
Federal Circuit Schools USPTO On Broadest Reasonable Claim Construction Foley & Lardner LLP
Sep
28
2015
USPTO Won't Stop Kyle Bass Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins